STOCK TITAN

[Form 4] Kellanova Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Kellanova (K) – Form 4 insider transaction

On 07/28/2025 the W.K. Kellogg Foundation Trust, a designated 10 % owner, sold 114,583 common shares of Kellanova at an average price of $79.7883, raising about $9.1 million. After the sale the Trust still controls 45,555,786 shares, so the disposition reduced its position by roughly 0.25 %. The trade was executed under a Rule 10b5-1 plan adopted 05/07/2024, implying it was pre-programmed rather than opportunistic.

No derivative securities were reported and no other insiders filed concurrent transactions. Given the Trust’s large residual stake, the sale appears routine portfolio management and does not meaningfully alter Kellanova’s insider ownership profile.

Kellanova (K) – Transazione interna Form 4

Il 28/07/2025, il W.K. Kellogg Foundation Trust, un azionista designato con il 10%, ha venduto 114.583 azioni ordinarie di Kellanova a un prezzo medio di 79,7883 dollari, incassando circa 9,1 milioni di dollari. Dopo la vendita, il Trust detiene ancora 45.555.786 azioni, quindi la cessione ha ridotto la sua posizione di circa lo 0,25%. L'operazione è stata effettuata nell'ambito di un piano Rule 10b5-1 adottato il 07/05/2024, il che implica che è stata programmata in anticipo e non dettata da opportunità di mercato.

Non sono stati riportati strumenti derivati né altri dirigenti hanno presentato transazioni simultanee. Considerando la consistente quota residua del Trust, la vendita sembra una normale gestione del portafoglio e non modifica in modo significativo il profilo di proprietà interna di Kellanova.

Kellanova (K) – Transacción interna Formulario 4

El 28/07/2025, el W.K. Kellogg Foundation Trust, un propietario designado con el 10%, vendió 114,583 acciones comunes de Kellanova a un precio promedio de 79.7883 dólares, recaudando aproximadamente 9.1 millones. Tras la venta, el Trust aún controla 45,555,786 acciones, por lo que la disposición redujo su posición en aproximadamente un 0.25%. La operación se ejecutó bajo un plan Rule 10b5-1 adoptado el 07/05/2024, lo que implica que fue preprogramada y no oportunista.

No se reportaron valores derivados ni otros insiders presentaron transacciones concurrentes. Dada la gran participación residual del Trust, la venta parece una gestión rutinaria de cartera y no altera significativamente el perfil de propiedad interna de Kellanova.

Kellanova (K) – Form 4 내부자 거래

2025년 7월 28일, 지정된 10% 소유주인 W.K. Kellogg Foundation Trust가 Kellanova의 보통주 114,583주를 평균 가격 $79.7883에 매도하여 약 910만 달러를 조달했습니다. 매도 후에도 Trust는 여전히 45,555,786주를 보유하고 있어 보유 지분이 약 0.25% 감소했습니다. 이 거래는 2024년 5월 7일 채택된 Rule 10b5-1 계획에 따라 사전 프로그램된 거래로, 기회주의적 거래가 아님을 의미합니다.

파생 증권은 보고되지 않았으며, 다른 내부자들도 동시 거래를 신고하지 않았습니다. Trust의 큰 잔여 지분을 고려할 때, 이번 매도는 일상적인 포트폴리오 관리로 보이며 Kellanova 내부자 소유 구조에 큰 변화를 주지 않습니다.

Kellanova (K) – Transaction interne Formulaire 4

Le 28/07/2025, le W.K. Kellogg Foundation Trust, un propriétaire désigné à 10 %, a vendu 114 583 actions ordinaires de Kellanova à un prix moyen de 79,7883 $, levant environ 9,1 millions de dollars. Après la vente, le Trust contrôle toujours 45 555 786 actions, réduisant ainsi sa position d'environ 0,25 %. La transaction a été réalisée dans le cadre d'un plan Rule 10b5-1 adopté le 07/05/2024, ce qui implique qu'elle était préprogrammée et non opportuniste.

Aucun titre dérivé n'a été déclaré et aucun autre initié n'a déposé de transactions simultanées. Étant donné la grande participation résiduelle du Trust, la vente semble relever d'une gestion de portefeuille de routine et ne modifie pas significativement le profil de détention interne de Kellanova.

Kellanova (K) – Form 4 Insider-Transaktion

Am 28.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein ausgewiesener 10%-Eigentümer, 114.583 Stammaktien von Kellanova zu einem durchschnittlichen Preis von 79,7883 USD und erzielte damit rund 9,1 Millionen USD. Nach dem Verkauf hält der Trust noch 45.555.786 Aktien, wodurch seine Position um etwa 0,25 % reduziert wurde. Der Handel wurde im Rahmen eines Rule 10b5-1-Plans ausgeführt, der am 07.05.2024 eingeführt wurde, was darauf hindeutet, dass es sich um eine vorprogrammierte und nicht opportunistische Transaktion handelt.

Es wurden keine Derivate gemeldet und keine anderen Insider reichten gleichzeitig Transaktionen ein. Angesichts des großen verbleibenden Anteils des Trusts scheint der Verkauf eine routinemäßige Portfolioverwaltung zu sein und verändert das Insiderbesitzprofil von Kellanova nicht wesentlich.

Positive
  • None.
Negative
  • Insider sale: 10 % owner disposed of 114,583 shares (~$9 million), signaling modest reduction in commitment.

Insights

TL;DR: Small, pre-planned sale; negligible impact on ownership structure.

The Trust’s disposition represents under 0.3 % of its holdings and less than 2 days’ average volume, limiting market signal strength. Execution via an established 10b5-1 plan further reduces informational content because timing was predetermined. The Trust remains a dominant shareholder with 45.6 million shares, preserving alignment with common shareholders. Overall, the filing is neutral for valuation or governance assessments.

Kellanova (K) – Transazione interna Form 4

Il 28/07/2025, il W.K. Kellogg Foundation Trust, un azionista designato con il 10%, ha venduto 114.583 azioni ordinarie di Kellanova a un prezzo medio di 79,7883 dollari, incassando circa 9,1 milioni di dollari. Dopo la vendita, il Trust detiene ancora 45.555.786 azioni, quindi la cessione ha ridotto la sua posizione di circa lo 0,25%. L'operazione è stata effettuata nell'ambito di un piano Rule 10b5-1 adottato il 07/05/2024, il che implica che è stata programmata in anticipo e non dettata da opportunità di mercato.

Non sono stati riportati strumenti derivati né altri dirigenti hanno presentato transazioni simultanee. Considerando la consistente quota residua del Trust, la vendita sembra una normale gestione del portafoglio e non modifica in modo significativo il profilo di proprietà interna di Kellanova.

Kellanova (K) – Transacción interna Formulario 4

El 28/07/2025, el W.K. Kellogg Foundation Trust, un propietario designado con el 10%, vendió 114,583 acciones comunes de Kellanova a un precio promedio de 79.7883 dólares, recaudando aproximadamente 9.1 millones. Tras la venta, el Trust aún controla 45,555,786 acciones, por lo que la disposición redujo su posición en aproximadamente un 0.25%. La operación se ejecutó bajo un plan Rule 10b5-1 adoptado el 07/05/2024, lo que implica que fue preprogramada y no oportunista.

No se reportaron valores derivados ni otros insiders presentaron transacciones concurrentes. Dada la gran participación residual del Trust, la venta parece una gestión rutinaria de cartera y no altera significativamente el perfil de propiedad interna de Kellanova.

Kellanova (K) – Form 4 내부자 거래

2025년 7월 28일, 지정된 10% 소유주인 W.K. Kellogg Foundation Trust가 Kellanova의 보통주 114,583주를 평균 가격 $79.7883에 매도하여 약 910만 달러를 조달했습니다. 매도 후에도 Trust는 여전히 45,555,786주를 보유하고 있어 보유 지분이 약 0.25% 감소했습니다. 이 거래는 2024년 5월 7일 채택된 Rule 10b5-1 계획에 따라 사전 프로그램된 거래로, 기회주의적 거래가 아님을 의미합니다.

파생 증권은 보고되지 않았으며, 다른 내부자들도 동시 거래를 신고하지 않았습니다. Trust의 큰 잔여 지분을 고려할 때, 이번 매도는 일상적인 포트폴리오 관리로 보이며 Kellanova 내부자 소유 구조에 큰 변화를 주지 않습니다.

Kellanova (K) – Transaction interne Formulaire 4

Le 28/07/2025, le W.K. Kellogg Foundation Trust, un propriétaire désigné à 10 %, a vendu 114 583 actions ordinaires de Kellanova à un prix moyen de 79,7883 $, levant environ 9,1 millions de dollars. Après la vente, le Trust contrôle toujours 45 555 786 actions, réduisant ainsi sa position d'environ 0,25 %. La transaction a été réalisée dans le cadre d'un plan Rule 10b5-1 adopté le 07/05/2024, ce qui implique qu'elle était préprogrammée et non opportuniste.

Aucun titre dérivé n'a été déclaré et aucun autre initié n'a déposé de transactions simultanées. Étant donné la grande participation résiduelle du Trust, la vente semble relever d'une gestion de portefeuille de routine et ne modifie pas significativement le profil de détention interne de Kellanova.

Kellanova (K) – Form 4 Insider-Transaktion

Am 28.07.2025 verkaufte der W.K. Kellogg Foundation Trust, ein ausgewiesener 10%-Eigentümer, 114.583 Stammaktien von Kellanova zu einem durchschnittlichen Preis von 79,7883 USD und erzielte damit rund 9,1 Millionen USD. Nach dem Verkauf hält der Trust noch 45.555.786 Aktien, wodurch seine Position um etwa 0,25 % reduziert wurde. Der Handel wurde im Rahmen eines Rule 10b5-1-Plans ausgeführt, der am 07.05.2024 eingeführt wurde, was darauf hindeutet, dass es sich um eine vorprogrammierte und nicht opportunistische Transaktion handelt.

Es wurden keine Derivate gemeldet und keine anderen Insider reichten gleichzeitig Transaktionen ein. Angesichts des großen verbleibenden Anteils des Trusts scheint der Verkauf eine routinemäßige Portfolioverwaltung zu sein und verändert das Insiderbesitzprofil von Kellanova nicht wesentlich.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST

(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KELLANOVA [ K ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/28/2025 07/28/2025 S 114,583 D $79.7883 45,555,786(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION TRUST

(Last) (First) (Middle)
ONE MICHIGAN AVE. EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KELLOGG W K FOUNDATION

(Last) (First) (Middle)
ONE MICHIGAN AVENUE EAST

(Street)
BATTLE CREEK MI 49017

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. 45,555,786 shares were owned following the reported transaction by the W.K. Kellogg Foundation Trust (the "Trust") of which LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company are Trustees and the W.K. Kellogg Foundation (the "Foundation") is the sole beneficiary.
Remarks:
The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.
Craig R. Carberry, Deputy General Counsel, The Northern Trust Company, as Corporate Trustee of the W.K. Kellogg Foundation Trust and signing for the W.K. Kellogg Foundation pursuant to a Power of Attorney dated August 30, 2017 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Kellanova shares did the W.K. Kellogg Foundation Trust sell?

The Trust sold 114,583 common shares on 07/28/2025.

What price did the insider shares of Kellanova (K) sell for?

The average sale price was $79.7883 per share.

How many Kellanova shares does the Trust still own after the transaction?

Post-sale, the Trust holds 45,555,786 shares.

Was the Kellanova insider sale pre-planned?

Yes. The sale was executed under a Rule 10b5-1 trading plan adopted on 05/07/2024.

Does the transaction materially change Kellanova’s insider ownership?

No. The sale reduced the Trust’s stake by only about 0.25 %.
Kellanova

NYSE:K

K Rankings

K Latest News

K Latest SEC Filings

K Stock Data

27.68B
344.99M
0.96%
82.32%
1.91%
Packaged Foods
Grain Mill Products
Link
United States
CHICAGO